LineaRx provides large-scale production of DNA sequences using polymerase chain reaction (PCR). Scaling PCR for high volume delivers highly purified DNA, without the complications of plasmids, for use in cell therapies, vaccines, diagnostics and gene therapies. We can meet CRO and CMO needs with linear DNA at any scale.
In the past 12 months, LineaRx has shipped over 8,000 milligrams of PCR-produced linear DNA for use in Diagnostic and Therapeutic applications. The Company has completed, or is progressing through, key milestones of a growing number of therapeutics research contracts for companies producing DNA and RNA vaccines and adoptive cell therapies.